Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

New Zeria compounds with alpha1-adrenoceptor-blocking effects

Feb. 1, 2000

OPC-41061 + furosemide: additive diuretic effect + beneficial effect on electrolytes

Jan. 31, 2000

Bayer presents new candidate treatment for ED at ESIR

Jan. 31, 2000

IC-351 improves erectile response to visual stimulation in men with mild to moderate ED

Jan. 31, 2000

New formulation of Xatral receives European approvals

Jan. 28, 2000

Takeda files for ED treatment in Europe

Jan. 27, 2000

Novel, highly water soluble salt of sildenafil suitable for intranasal administration

Jan. 26, 2000

New inhibitors of cGMP-PDE in development at BMS for ED and cardiovascular conditions

Jan. 24, 2000

Melanocortin receptor agonists and their use disclosed by Merck

Jan. 21, 2000

Afferon steps up development of RTX for treatment of urge incontinence

Jan. 21, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...